Four randomized controlled trials have compared mortality and morbidity of tight glycemic control versus conventional glucose for intensive care unit (ICU) patients. Two trials showed a positive outcome. However, one single-center trial and a large multicenter trial had negative results. The positive trials used accurate portable lab analyzers. The negative trial allowed the use of meters. The portable analyzer measures in filtered plasma, minimizing the interference effects.
OptiScan Biomedical Corporation is developing a continuous glucose monitor using centrifuged plasma and mid-infrared spectroscopy for use in ICU medicine. The OptiScanner draws approximately 0.1 ml of blood every 15 min and creates a centrifuged plasma sample. Internal quality control minimizes sample preparation error. Interference adjustment using this technique has been presented at the Society of Critical Care Medicine in separate studies since 2006.
Method:
A good laboratory practice study was conducted on three Yorkshire pigs using a central venous catheter over 6 h while performing a glucose challenge. Matching Yellow Springs Instrument glucose readings were obtained.
Results:
Some 95.7% of the predicted values were in the Clarke Error Grid A zone and 4.3% in the B zone. Of those in the B zone, all were within 3.3% of the A zone boundaries. The coefficient of determination (R2) was 0.993. The coefficient of variance was 5.02%. Animal necropsy and blood panels demonstrated safety.
Conclusion:
The OptiScanner investigational device performed safely and accurately in an animal model. Human studies using the device will begin soon.
Van den BergheGWoutersPWeekersFVerwaestCBruyninckxFSchetzMVlasselaersDFerdinandePLauwersPBouillonR. Intensive insulin therapy in the critically ill patients. N Engl J Med.2001;345 (19): 1359–67.
2.
Van den BergheGWilmerAHermansGMeerssemanWWoutersPJMilantsIVan WijngaerdenEBobbaersHBouillonR. Intensive insulin therapy in the medical ICU. N Engl J Med.2006;354 (5): 449–61.
3.
VlasselaersDMilantsIDesmetLWoutersPJVanhorebeekIVan den HeuvelIMesottenDCasaerMPMeyfroidtGIngelsCMullerJVan CromphautSSchetzMVan den BergheG. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomized controlled study. Lancet.2009;373 (9663): 547–56.
4.
KrinsleyJS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc.2004;79 (8): 992–1000.
5.
BochicchioGVJoshiMBochicchioKMPyleAJohnsonSBMeyerWLumpkinsKScaleaTM. Early hyperglycemic control is important in critically injured trauma patients. J Trauma.2007;63 (6): 1353–8.
6.
ScaleaTMBochicchioGVBochicchioKMJohnsonSBJoshiMPyleA. Tight glycemic control in critically injured trauma patients. Ann Surg.2007;246 (4): 605–10.
MannEAPidcokeHFSalinasJHolcombJBWolfSEWadeCE. The impact of intensive insulin protocols and restrictive blood transfusion strategies on glucose measurement in American Burn Association (ABA) verified burn centers. J Burn Care Res.2008;29 (5): 718–23.
9.
EgiMBellomoRStachowskiEFrenchCJHartG. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology.2006;105 (2): 244–52.
10.
AliNO'BrienJMJrDunganKPhillipsGMarshCBLemeshowSConnorsAFJrPreiserJC. Glucose variability is independently associated with mortality in patients with sepsis. Crit Care Med.2007;35: A924.
11.
KrinsleyJS. Glycemic variability: a strong, independent predictor of mortality in critically ill patients. Crit Care Med.2008;36 (11): 3008–13.
12.
BrunkhorstFMEngelCBloosFMeier-HellmannARagallerMWeilerNMoererOGruendlingMOppertMGrondSOlthoffDJaschinskiUJohnSRossaintRWelteTSchaeferMKernPKuhntEKiehntopfMHartogCNatansonCLoefflerMReinhartK, German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med.2008;358 (2);125–39.
13.
PreiserJC. Intensive glycemic control in medico-surgical patients: the European GluControl Trial. SCCM Congress, Orlando, FL, February 19, 2007.
14.
The NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med.2009;369 (13): 1283–97.
15.
InzucchiSESiegelMD. Glucose control in the ICU—how tight is too tight?. N Engl J Med.2009;360 (13): 1346–9.
16.
KrinsleyJSPreiserJC. Moving beyond tight glucose control to safe effective glucose control. Crit Care.2008;12 (3): 149.
17.
KanjiSBuffieJHuttonBBuntingPSSinghAMcDonaldKFergussonDMcIntyreLAHebertPC. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med.2005;33 (12): 2778–85.
18.
TangZDuXLouieRFKostGJ. Effects of pH on glucose measurements with handheld glucose meters and a portable glucose analyzer for point-of-care testing. Arch Pathol Lab Med.2000;124 (4): 577–82.
19.
MannEASalinasJPidcokeHFWolfSEHolcombJBWadeCE. Error rates resulting from anemia can be corrected in multiple commonly used point-of-care glucometers. J Trauma.2008;64 (1): 15–20.
20.
TangZLeeJHLouieRFKostGJ. Effects of different hematocrit levels on glucose measurements with handheld meters for point-of-care testing. Arch Pathol Lab Med.2000;124 (8): 1135–40.
21.
TangZLouieRFPayesMChangKCKostGJ. Oxygen effects on glucose measurements with a reference analyzer and three handheld meters. Diabetes Technol Ther.2000;2 (3): 349–62.
22.
TangZPDuXGLouieRFKostGJ. Drug interference on glucose measurements with six handheld glucose meters and a portable analyzer for point-of-care testing in critical care. 51st Annual AACC Conference, New Orleans, LA, July 25–29, 1999. Abstract 97.
23.
HarrisG. FDA pushes for accurate glucose monitors. New York Times. July 19, 2009.
24.
HamburgM. FDA's Center for Devices and Radiological Health's Response. Department of Health and Human Services letter from the Commission of Food and Drugs, FDA. June 24, 2009.
25.
ScottMGBrunsDEBoydJCSacksDB. Tight glycemic control in the intensive care unit: are glucose meters up to the task?. Clin Chem.2009;55 (1): 18–20.
26.
AragonD. Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control. Am J Crit Care.2006: 15 (4): 370–7.
27.
WernermanJ. International Symposium on Intensive Care and Emergency Medicine Conference. March 25, 2009.
28.
KimYJYoonG. Prediction of glucose in whole blood by near-infrared spectroscopy: influence of wavelength region, preprocessing, and hemoglobin concentration. J Biomed Opt.2006;11 (4): 041128.
29.
DruyMA. Applications for mid-IR spectroscopy in the pharmaceutical process environment. Spectroscopy.2004;19 (2): 60–4.
30.
HeiseHMMarbachRKoschinskyTGriesFA. Multicomponent assay for blood substrates in human plasma by mid-infrared spectroscopy and its evaluation for clinical analysis. Appl Spectrosc.1994;48 (1): 85–95.
31.
Kruse-JarresJDJanatschGGlessUMarbachRHeiseHM. Glucose and other constituents of blood determined by ATR-FTIR-spectroscopy. Clin Chem.1990;36 (2): 401–2.
32.
FinkielmanJDOyenLJAfessaB. Agreement between bedside blood and plasma glucose measurement in the ICU setting. Chest.2005;127 (5): 1749–51.
33.
BrunkhorstFMWahlHG. Blood glucose measurements in the critically ill: more than just a blood draw. Crit Care.2006;10 (6): 178.
34.
KrinsleyJZhengPHallDMagarianP. ICU validation of the OptiScanner, a continuous glucose monitoring device. Crit Care Med.2006;34 (12): A67.
35.
KrinsleyJHallDZhengPMagarianP. Validation of the OptiScanner, a continuous glucose and lactate point of care monitor. SCCM 36th Critical Congress, February 2007. Poster 255.
36.
BochicchioGBochicchioKLettichKLambertPHerreraALumpkinsKMagarianPScaleaT. Cutting edge technology in tight glycemic control. SCCM 37th Critical Care Congress, February 2008. Poster 519.
37.
BochicchioGBochicchioKLettichKLambertPHerreraALumpkinsKMagarianPScaleaT. Mid infrared spectroscopy (MIS) is highly accurate in measuring glucose in ICU patients. SCCM 38th Critical Care Congress, February 2009. Poster 262.
